secwatch.observer — SEC 8-K summary
======================================

Issuer:     TELA Bio, Inc. (TELA)
CIK:        0001561921
Form:       8-K
Filed at:   2026-08-31T11:05:34+00:00
Accession:  0001104659-26-103548
Event type: other_material
Sentiment:  negative
Materiality: 0.60
Item codes: 2.05, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TELA Bio cuts workforce 20%, CFO/COO Cuca steps down; annual savings $17M
-------------------------------------------------------------------------

- Reduces workforce ~20% (201 to 160 employees); expects $1.5M Q3 2026 restructuring charge.
- Annual operating expense reduction of $17.0M (18%) via headcount and external resource streamlining.
- Roberto Cuca steps down as CFO/COO and Corporate Secretary effective Aug 31, 2026; Heather Getz named principal financial officer.
- Initiative expected to extend cash runway into 2028; details on Q3 2026 earnings call in early November.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1561921/000110465926103548/0001104659-26-103548-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1561921/000110465926103548/tm2624299d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-103548

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer